Authors

John Paul Diaz, Miami Cancer InstituteFollow
Troy Gatcliffe, Miami Cancer InstituteFollow
Zuanel Diaz, Miami Cancer InstituteFollow
Eric Schroeder, Miami Cancer InstituteFollow
Nicholas Lambrou, Miami Cancer InstituteFollow
Nicole Eiseler, Miami Cancer InstituteFollow
Thomas Morrissey, Baptist Health South FloridaFollow

Fanconi anemia repair pathway as a predictor of anti-tumor activity of pembrolizumab: interim analysis of open-label, single-arm phase II trial

Publication Date

2021

Content Type

Article

Publisher's Site:

View at Publisher Website

Additional Authors:

Additional authors and institutional affiliations

Citation

Gynecologic Oncology (2021) 162:S66-S67